Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) Ongoing Safety of Sernova's Clinical Trial Confirmed L ondon, Ontario - TheNewswire - February 18, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage company and leader in regenerative medicine therapeutics, is p...
(TheNewswire) Prescient Reports Edition 01-21 V192 https://www.prescientreports.com/2020-saw-the-emergence-of-significant-medical-advancements/ Biotech Section Author: R. Hutchison The POINT 2020 -- The Em...
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2021) - Sernova Corp. (TSXV: SVA) (OTCQB: SEOVF) - The company announces collaborations with global pharmaceutical companies to work with the Sernova Cell Pouch System. If you cannot view the video above, please visit: https:...
Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 Million Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / LONDON, ON , Feb. 4, 2021 /CNW/ - Sernova Corp. ("Sernova" or th...
(TheNewswire) LONDON, ONTARIO – TheNewswire - February 4, 2021 – Sernova Corp. (TSXV:SVA) (OTCQB:SEOVF) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce the start of trading of Sernova ...
Sernova (SEOVF) to sell 8.35M units at a price of C$1.20 per unit for gross proceeds of ~C$10M via underwriters.Net proceeds will be used to advance the company's clinical development program, including its US Phase I/II Cell Pouch clinical trial, expand R&D programs, including...
Sernova Corp. Announces C$10 Million Bought Deal Offering of Units Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / LONDON, ON , Feb. 3, 2021 /CNW/ - Sernova Corp. ("Sernova" or the "Company") ...
(TheNewswire) LONDON, ONTARIO – TheNewswire - February 3, 202 1 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that Dr. Sam Wiseman, BSc, MD, ...
(TheNewswire) London, ON – TheNewswire – February 2 2021 - On the heels of recent partnership interest and conference presentations , Global News London’s Jess Brady took time took time to truly explore ...
(TheNewswire) Sernova’s Cell Pouch platform and cell therapy expertise being used in multiple collaborations with global pharmaceutical companies LONDON, ONTARIO – TheNewswire - January 28, 2021 – Sernova Corp. (TSXV...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...